Health Care Select Sector SPDR Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (58)

Latest Posts

About This Stock More About This Stock
Bear Market Rally Lifts HealthCare Stocks Off Bottom
Article By: Rod Raynovich
Wednesday, June 22, 2022 5:36 AM EDT
Clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma.
In this article: LLY, UNH, XLV, CRSP Also: CCXI, EVH, MRTX, MDGL, VCYT
Read
What’s Next For Biotech And Healthcare
Article By: Tarun Chandra, CFA
Monday, June 13, 2022 9:41 AM EDT
Biotechs have sold off this year along with the broader market. Declines have been more pronounced than prior pullbacks. However, healthcare continues to outperform.
In this article: IBB, SPY, XLV
Read
Healthcare Stocks Lead The Way Up As The Market Fades
Article By: Rod Raynovich
Monday, April 11, 2022 3:30 PM EDT
With inflation and energy costs soaring, the Fed ever threatening with higher rates and headlines from the war in Ukraine investors are seeking more defensive positions.
In this article: IWM, XBI, XLV Also: UNH, IHF, ABBV, BMY, MRK, PFE, RHHBY, REGN
Read
The Hawks Are Circling - How To Protect Your Portfolio
Article By: Keith Schneider
Sunday, April 10, 2022 9:51 AM EDT
No, this is not about the Atlanta Hawks hoping to get into the NBA playoffs. We’re talking about financial hawks that grew in number this week, and the game these hawks are playing will affect not only their net worth, but your net worth as well.
In this article: VTV, SPX, XHB, XLE, XLV, IYT, SMH, XLP, XLU, XLY
Read
Tough Slogging Ahead For Investors, Diversification Is Important
Article By: Rod Raynovich
Monday, March 7, 2022 2:13 PM EDT
Speculative small/mid-cap biotech stocks hit new lows this past week with the XBI at a “triple bottom” about the $84 level only 10 points above the March 2020 lows.
In this article: XBI, XLE, XLV Also: LGND, SGEN, SRPT, EVH, CRSP, MDGL
Read

Latest Tweets for $XLV

No tweets yet!

PARTNER HEADLINES